Viewing Study NCT06632561


Ignite Creation Date: 2025-12-24 @ 1:05 PM
Ignite Modification Date: 2025-12-28 @ 11:36 AM
Study NCT ID: NCT06632561
Status: COMPLETED
Last Update Posted: 2024-10-09
First Post: 2024-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Benefits of Empagliflozin in Patients With Heart Failure and Reduced Ejection Fraction Without Diabetes Mellitus
Sponsor: Ashraf Wasfy Beshay Aziz
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module